Capecitabine 500mg tablets
NHS hospitals in England used £16,914,375 of indicative cost of Capecitabine 500mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 2.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Capecitabine 500mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Capecitabine 500mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £912,846 |
| The Clatterbridge Cancer Centre Nhs Ft | £657,541 |
| The Royal Marsden Nhs Foundation Trust | £562,693 |
| Sheffield Teaching Hospitals Nhs Trust | £457,130 |
| Univ Hpl B/Ham Nhs Foundation Trust | £414,616 |
| Nottingham University Hospitals Trust | £401,463 |
| Southend Univ Hosp Nhs Foundation Trust | £373,338 |
| South Tees Hosp Nhs Foundation Trust | £355,382 |
| South Tyneside And Sunderland Nhs Ft | £325,535 |
| Guy's & St Thomas' Nhs Foundation Trust | £289,665 |
The primary-care picture
Capecitabine is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Capecitabine medicine page.